SLU's vaccine center awarded $2.9 million to study new TB vaccine

(Saint Louis University) Daniel Hoft, M.D., Ph.D., director of the division of infectious diseases at Saint Louis University has received funding from the Gates Foundation to research a potential vaccine against tuberculosis.